NPI: 1548639792 · BAKERSFIELD, CA 93312 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/17/2015
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/17/2015 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 5,575 | $606K |
| 2020 | 7,934 | $909K |
| 2021 | 6,674 | $729K |
| 2022 | 4,747 | $350K |
| 2023 | 6,047 | $808K |
| 2024 | 5,019 | $683K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90966 | 10,715 | 375 | $1.72M | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,624 | 432 | $1.54M |
| S9339 | Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | 4,901 | 186 | $811K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,848 | 944 | $3K |
| 90674 | 35 | 33 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | 975 | 467 | $1K |
| 85041 | 462 | 452 | $906.79 | |
| 83550 | 217 | 213 | $888.77 | |
| 82728 | 492 | 488 | $888.77 | |
| 83540 | 479 | 475 | $888.77 | |
| 85048 | 462 | 452 | $888.77 | |
| 83970 | 184 | 180 | $308.38 | |
| A4657 | Syringe, with or without needle, each | 134 | 130 | $291.20 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 18 | 13 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 396 | 291 | $0.00 |
| 82570 | 54 | 26 | $0.00 |